SM
OTLK icon

Sabby Management’s Outlook Therapeutics OTLK Stock Holding History

Sabby Management’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-161,617
Closed -$1.94M – 118
2020
Q1 		$1.94M Buy
161,617
+142,170
+731% +$2.36M 0.81% 17
2019
Q4 		$229K Buy
+19,447
New +$453K 0.06% 47
2019
Q1 		– Sell
-17,415
Closed -$1.39M – 110
2018
Q4 		$1.39M Sell
17,415
-3,553
-17% -$437K 0.31% 31
2018
Q3 		$3.32M Sell
20,968
-2,112
-9% -$297K 0.42% 35
2018
Q2 		$3.12M Buy
23,080
+9,903
+75% +$1.46M 0.48% 34
2018
Q1 		$1.88M Buy
13,177
+181
+1% +$32.3K 0.22% 40
2017
Q4 		$2.7M Sell
12,996
-1,904
-13% -$395K 0.25% 46
2017
Q3 		$3.27M Buy
14,900
+114
+0.8% +$20.7K 0.21% 47
2017
Q2 		$2.37M Buy
14,786
+796
+6% +$225K 0.16% 64
2017
Q1 		$6M Hold
13,990
– – 0.32% 42
2016
Q4 		$6.74M Sell
13,990
-189
-1% -$106K 0.39% 42
2016
Q3 		$9.64M Buy
14,179
+1,248
+10% +$793K 0.36% 47
2016
Q2 		$7.04M Buy
+12,931
New +$7.71M 0.37% 45

Other funds holding OTLK

LA
LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Sabby Management's OTLK Position: Q2 2020 in Review

Sabby Management sold out of Outlook Therapeutics (OTLK) in Q2 2020, closing a stake of 161,617 shares — an estimated $1.94M sold.

Sabby Management first reported a position in OTLK in Q2 2016 and held it in 13 quarters. The position peaked at $9.64M in Q3 2016. 20 funds tracked by Wall St. Rank hold OTLK as of Q2 2020.

  • Sabby Management reported no remaining Outlook Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Sabby Management sold 161,617 Outlook Therapeutics shares in Q2 2020, an estimated $1.94M.
  • Sabby Management first reported a position in Outlook Therapeutics in Q2 2016 and held it in 13 quarters.
  • Sabby Management's Outlook Therapeutics position peaked at $9.64M in Q3 2016.
  • 20 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2020.

Based on Sabby Management's 13F filing for Q2 2020, filed 14 Aug 2020.